BioXpress Therapeutics SA

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Seagen, RemeGen Partner Outside Asia, E

BioXpress Therapeutics , known for developing monoclonal antibody biosimilars, has entered into a partnership with contract development and manufacturing organization Abzena – that provides patient

Roche Holding AG ’s Actemra (tocilizumab) has received its latest in a string of US Food and Drug Administration approvals, for interstitial lung disease associated with systemic sclerosis (SSc-ILD),